| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 2,219 | 5,274 | ||
| Trade accounts receivable, less allowance for doubtful accounts of 50 and 40, respectively | 12,749 | 12,416 | ||
| Prepaid expenses | 4,460 | 4,970 | ||
| Income taxes receivable | 0 | 438 | ||
| Other current assets | 973 | 2,222 | ||
| Total current assets | 20,401 | 25,320 | ||
| Net property and equipment | 41,413 | 42,232 | ||
| Intangible assets, net | 2,324 | 2,422 | ||
| Goodwill | 66,152 | 66,152 | ||
| Operating lease right-of-use assets | 1,269 | 1,409 | ||
| Deferred contract costs, net | 1,921 | 1,573 | ||
| Other noncurrent assets | 2,239 | 2,279 | ||
| Total assets | 135,719 | 141,387 | ||
| Current portion of notes payable, net of unamortized debt issuance costs | 4,012 | 3,928 | ||
| Accounts payable | 1,094 | 1,180 | ||
| Accrued wages and bonuses | 7,124 | 5,685 | ||
| Accrued expenses | 3,900 | 5,614 | ||
| Dividends payable | 2,698 | 2,776 | ||
| Deferred revenue | 17,814 | 15,603 | ||
| Income taxes payable | 1,459 | 0 | ||
| Other current liabilities | 465 | 1,140 | ||
| Total current liabilities | 38,566 | 35,926 | ||
| Notes payable, net of current portion and unamortized debt issuance costs | 76,025 | 77,029 | ||
| Deferred income taxes | 3,451 | 3,500 | ||
| Other long-term liabilities | 3,363 | 3,604 | ||
| Total liabilities | 121,405 | 120,059 | ||
| Common stock, 0.001 par value authorized 110,000,000 shares, issued 31,954,158 in 2025 and 31,072,144 in 2024, outstanding 22,657,421 in 2025 and 23,083,116 in 2024 | 32 | 32 | ||
| Additional paid-in capital | 181,783 | 180,858 | ||
| Retained earnings (accumulated deficit) | -15,470 | -16,894 | ||
| Treasury stock, at cost 9,296,737 and 7,989,028 common shares in 2025 and 2024, respectively | 152,031 | 142,668 | ||
| Total shareholders equity | 14,314 | 21,328 | ||
| Total liabilities and shareholders equity | 135,719 | 141,387 | ||
NATIONAL RESEARCH CORP (NRC)
NATIONAL RESEARCH CORP (NRC)